Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2024-09-30
• Last 15 days FTD volume: A$1.54 M
• Last 3 months FTD volume: A$3.34 M
• Last year FTD volume: A$3.34 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$6.7 M	A$65.32 M	🇺🇸 USA
Royalty Pharma RPRX	A$6.21 M	A$12.06 M	🇬🇧 UK
Palatin Technologies PTN	A$0.12 M	A$2.24 M	🇺🇸 USA
Eli Lilly LLY	A$47.41 M	A$0.15 B	🇺🇸 USA
AbbVie ABBV	A$0.10 B	A$0.17 B	🇺🇸 USA
Pfizer PFE	A$0.17 B	A$0.52 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	A$1.92 M	A$2.39 M	🇺🇸 USA
Athersys ATHX	A$0.09 M	A$0.71 M	🇺🇸 USA